nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—CYP1A2—chronic obstructive pulmonary disease	0.444	1	CbGaD
Clarithromycin—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.056	0.162	CbGbCtD
Clarithromycin—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.056	0.162	CbGbCtD
Clarithromycin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0439	0.127	CbGbCtD
Clarithromycin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0357	0.103	CbGbCtD
Clarithromycin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0241	0.0699	CbGbCtD
Clarithromycin—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0235	0.0681	CbGbCtD
Clarithromycin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.023	0.0667	CbGbCtD
Clarithromycin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0205	0.0594	CbGbCtD
Clarithromycin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0201	0.0582	CbGbCtD
Clarithromycin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.019	0.055	CbGbCtD
Clarithromycin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.012	0.0349	CbGbCtD
Clarithromycin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0114	0.0329	CbGbCtD
Clarithromycin—Roxithromycin—CYP1A2—chronic obstructive pulmonary disease	0.00104	0.275	CrCbGaD
Clarithromycin—Azithromycin—CYP1A2—chronic obstructive pulmonary disease	0.00104	0.275	CrCbGaD
Clarithromycin—Telithromycin—CYP1A2—chronic obstructive pulmonary disease	0.00101	0.267	CrCbGaD
Clarithromycin—Erythromycin—CYP1A2—chronic obstructive pulmonary disease	0.000691	0.183	CrCbGaD
Clarithromycin—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000291	0.0104	CbGpPWpGaD
Clarithromycin—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00028	0.01	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000259	0.00929	CbGpPWpGaD
Clarithromycin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000256	0.00919	CbGpPWpGaD
Clarithromycin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000247	0.00887	CbGpPWpGaD
Clarithromycin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00131	CcSEcCtD
Clarithromycin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00131	CcSEcCtD
Clarithromycin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00131	CcSEcCtD
Clarithromycin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00131	CcSEcCtD
Clarithromycin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00131	CcSEcCtD
Clarithromycin—CYP3A7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000235	0.00844	CbGpPWpGaD
Clarithromycin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000235	0.00131	CcSEcCtD
Clarithromycin—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00131	CcSEcCtD
Clarithromycin—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00131	CcSEcCtD
Clarithromycin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00131	CcSEcCtD
Clarithromycin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000234	0.00131	CcSEcCtD
Clarithromycin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000234	0.00131	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.0013	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000234	0.0013	CcSEcCtD
Clarithromycin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.0013	CcSEcCtD
Clarithromycin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000233	0.0013	CcSEcCtD
Clarithromycin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00129	CcSEcCtD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000231	0.00828	CbGpPWpGaD
Clarithromycin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00128	CcSEcCtD
Clarithromycin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00128	CcSEcCtD
Clarithromycin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00128	CcSEcCtD
Clarithromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00023	0.00825	CbGpPWpGaD
Clarithromycin—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.00023	0.00825	CbGpPWpGaD
Clarithromycin—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00128	CcSEcCtD
Clarithromycin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00128	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000229	0.00128	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.00127	CcSEcCtD
Clarithromycin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00127	CcSEcCtD
Clarithromycin—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00127	CcSEcCtD
Clarithromycin—CYP3A7—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000227	0.00814	CbGpPWpGaD
Clarithromycin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00126	CcSEcCtD
Clarithromycin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00126	CcSEcCtD
Clarithromycin—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000225	0.00807	CbGpPWpGaD
Clarithromycin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00125	CcSEcCtD
Clarithromycin—Infection—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00125	CcSEcCtD
Clarithromycin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000222	0.00798	CbGpPWpGaD
Clarithromycin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00124	CcSEcCtD
Clarithromycin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00124	CcSEcCtD
Clarithromycin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.00124	CcSEcCtD
Clarithromycin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00123	CcSEcCtD
Clarithromycin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00123	CcSEcCtD
Clarithromycin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00123	CcSEcCtD
Clarithromycin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000221	0.00123	CcSEcCtD
Clarithromycin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00123	CcSEcCtD
Clarithromycin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00122	CcSEcCtD
Clarithromycin—Infection—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00122	CcSEcCtD
Clarithromycin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00122	CcSEcCtD
Clarithromycin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00122	CcSEcCtD
Clarithromycin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000218	0.00122	CcSEcCtD
Clarithromycin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00121	CcSEcCtD
Clarithromycin—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00121	CcSEcCtD
Clarithromycin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00121	CcSEcCtD
Clarithromycin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000216	0.00121	CcSEcCtD
Clarithromycin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00121	CcSEcCtD
Clarithromycin—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000216	0.00776	CbGpPWpGaD
Clarithromycin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000215	0.0012	CcSEcCtD
Clarithromycin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00119	CcSEcCtD
Clarithromycin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00118	CcSEcCtD
Clarithromycin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00117	CcSEcCtD
Clarithromycin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00021	0.00117	CcSEcCtD
Clarithromycin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000209	0.00751	CbGpPWpGaD
Clarithromycin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00116	CcSEcCtD
Clarithromycin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00115	CcSEcCtD
Clarithromycin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000206	0.00115	CcSEcCtD
Clarithromycin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00115	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00115	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00115	CcSEcCtD
Clarithromycin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00114	CcSEcCtD
Clarithromycin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00114	CcSEcCtD
Clarithromycin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00113	CcSEcCtD
Clarithromycin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000203	0.00113	CcSEcCtD
Clarithromycin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.00726	CbGpPWpGaD
Clarithromycin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00112	CcSEcCtD
Clarithromycin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00112	CcSEcCtD
Clarithromycin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00112	CcSEcCtD
Clarithromycin—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000201	0.00721	CbGpPWpGaD
Clarithromycin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00112	CcSEcCtD
Clarithromycin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00112	CcSEcCtD
Clarithromycin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00111	CcSEcCtD
Clarithromycin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00111	CcSEcCtD
Clarithromycin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00111	CcSEcCtD
Clarithromycin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000198	0.00111	CcSEcCtD
Clarithromycin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.0011	CcSEcCtD
Clarithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.00709	CbGpPWpGaD
Clarithromycin—Injury—Prednisone—chronic obstructive pulmonary disease	0.000197	0.0011	CcSEcCtD
Clarithromycin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00109	CcSEcCtD
Clarithromycin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.00109	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00109	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00109	CcSEcCtD
Clarithromycin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00108	CcSEcCtD
Clarithromycin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00108	CcSEcCtD
Clarithromycin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00108	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00108	CcSEcCtD
Clarithromycin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000194	0.00696	CbGpPWpGaD
Clarithromycin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00108	CcSEcCtD
Clarithromycin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00108	CcSEcCtD
Clarithromycin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00108	CcSEcCtD
Clarithromycin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00108	CcSEcCtD
Clarithromycin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00107	CcSEcCtD
Clarithromycin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00107	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00106	CcSEcCtD
Clarithromycin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00106	CcSEcCtD
Clarithromycin—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000191	0.00684	CbGpPWpGaD
Clarithromycin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00106	CcSEcCtD
Clarithromycin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00106	CcSEcCtD
Clarithromycin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00105	CcSEcCtD
Clarithromycin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000189	0.00105	CcSEcCtD
Clarithromycin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00105	CcSEcCtD
Clarithromycin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00104	CcSEcCtD
Clarithromycin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00104	CcSEcCtD
Clarithromycin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00104	CcSEcCtD
Clarithromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000186	0.00669	CbGpPWpGaD
Clarithromycin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00104	CcSEcCtD
Clarithromycin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000186	0.00668	CbGpPWpGaD
Clarithromycin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00104	CcSEcCtD
Clarithromycin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00104	CcSEcCtD
Clarithromycin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.00104	CcSEcCtD
Clarithromycin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00103	CcSEcCtD
Clarithromycin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.00103	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00103	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00103	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00103	CcSEcCtD
Clarithromycin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00102	CcSEcCtD
Clarithromycin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00102	CcSEcCtD
Clarithromycin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00102	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00101	CcSEcCtD
Clarithromycin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.000999	CcSEcCtD
Clarithromycin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000179	0.000999	CcSEcCtD
Clarithromycin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000179	0.00642	CbGpPWpGaD
Clarithromycin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000178	0.000994	CcSEcCtD
Clarithromycin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000178	0.000994	CcSEcCtD
Clarithromycin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.000994	CcSEcCtD
Clarithromycin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.000994	CcSEcCtD
Clarithromycin—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000178	0.0064	CbGpPWpGaD
Clarithromycin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000178	0.000991	CcSEcCtD
Clarithromycin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000983	CcSEcCtD
Clarithromycin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.000982	CcSEcCtD
Clarithromycin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.000982	CcSEcCtD
Clarithromycin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.000981	CcSEcCtD
Clarithromycin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000176	0.000978	CcSEcCtD
Clarithromycin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.000978	CcSEcCtD
Clarithromycin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000175	0.000976	CcSEcCtD
Clarithromycin—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000175	0.00629	CbGpPWpGaD
Clarithromycin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000175	0.000974	CcSEcCtD
Clarithromycin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000175	0.000974	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000971	CcSEcCtD
Clarithromycin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.000963	CcSEcCtD
Clarithromycin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.000959	CcSEcCtD
Clarithromycin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000957	CcSEcCtD
Clarithromycin—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00017	0.0061	CbGpPWpGaD
Clarithromycin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000943	CcSEcCtD
Clarithromycin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000939	CcSEcCtD
Clarithromycin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000939	CcSEcCtD
Clarithromycin—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000168	0.00605	CbGpPWpGaD
Clarithromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.00599	CbGpPWpGaD
Clarithromycin—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.00599	CbGpPWpGaD
Clarithromycin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000166	0.000926	CcSEcCtD
Clarithromycin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.000926	CcSEcCtD
Clarithromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.00596	CbGpPWpGaD
Clarithromycin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000166	0.000926	CcSEcCtD
Clarithromycin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000924	CcSEcCtD
Clarithromycin—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000165	0.00592	CbGpPWpGaD
Clarithromycin—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.00589	CbGpPWpGaD
Clarithromycin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000163	0.000907	CcSEcCtD
Clarithromycin—SLC22A7—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000163	0.00584	CbGpPWpGaD
Clarithromycin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.000902	CcSEcCtD
Clarithromycin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000162	0.000902	CcSEcCtD
Clarithromycin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000162	0.0058	CbGpPWpGaD
Clarithromycin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00089	CcSEcCtD
Clarithromycin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00089	CcSEcCtD
Clarithromycin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000888	CcSEcCtD
Clarithromycin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.000884	CcSEcCtD
Clarithromycin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000876	CcSEcCtD
Clarithromycin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.000875	CcSEcCtD
Clarithromycin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000871	CcSEcCtD
Clarithromycin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000155	0.00557	CbGpPWpGaD
Clarithromycin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00086	CcSEcCtD
Clarithromycin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00086	CcSEcCtD
Clarithromycin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000853	CcSEcCtD
Clarithromycin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000852	CcSEcCtD
Clarithromycin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000151	0.000843	CcSEcCtD
Clarithromycin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00084	CcSEcCtD
Clarithromycin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000832	CcSEcCtD
Clarithromycin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000832	CcSEcCtD
Clarithromycin—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000149	0.00533	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000147	0.00528	CbGpPWpGaD
Clarithromycin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00528	CbGpPWpGaD
Clarithromycin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000146	0.000814	CcSEcCtD
Clarithromycin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000814	CcSEcCtD
Clarithromycin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000812	CcSEcCtD
Clarithromycin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.0008	CcSEcCtD
Clarithromycin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000143	0.0008	CcSEcCtD
Clarithromycin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000793	CcSEcCtD
Clarithromycin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000793	CcSEcCtD
Clarithromycin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000792	CcSEcCtD
Clarithromycin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000792	CcSEcCtD
Clarithromycin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000141	0.000788	CcSEcCtD
Clarithromycin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.000788	CcSEcCtD
Clarithromycin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000785	CcSEcCtD
Clarithromycin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000783	CcSEcCtD
Clarithromycin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000777	CcSEcCtD
Clarithromycin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000776	CcSEcCtD
Clarithromycin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000774	CcSEcCtD
Clarithromycin—Depression—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000774	CcSEcCtD
Clarithromycin—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000139	0.00498	CbGpPWpGaD
Clarithromycin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000138	0.000772	CcSEcCtD
Clarithromycin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000762	CcSEcCtD
Clarithromycin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000755	CcSEcCtD
Clarithromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.00486	CbGpPWpGaD
Clarithromycin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.00485	CbGpPWpGaD
Clarithromycin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000753	CcSEcCtD
Clarithromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00483	CbGpPWpGaD
Clarithromycin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00075	CcSEcCtD
Clarithromycin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000749	CcSEcCtD
Clarithromycin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000748	CcSEcCtD
Clarithromycin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000747	CcSEcCtD
Clarithromycin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000747	CcSEcCtD
Clarithromycin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000744	CcSEcCtD
Clarithromycin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000733	CcSEcCtD
Clarithromycin—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000131	0.00472	CbGpPWpGaD
Clarithromycin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000732	CcSEcCtD
Clarithromycin—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00467	CbGpPWpGaD
Clarithromycin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00467	CbGpPWpGaD
Clarithromycin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000723	CcSEcCtD
Clarithromycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00461	CbGpPWpGaD
Clarithromycin—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.00455	CbGpPWpGaD
Clarithromycin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000705	CcSEcCtD
Clarithromycin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000702	CcSEcCtD
Clarithromycin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000126	0.0007	CcSEcCtD
Clarithromycin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000697	CcSEcCtD
Clarithromycin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000693	CcSEcCtD
Clarithromycin—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000123	0.00442	CbGpPWpGaD
Clarithromycin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000684	CcSEcCtD
Clarithromycin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000681	CcSEcCtD
Clarithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.00437	CbGpPWpGaD
Clarithromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00433	CbGpPWpGaD
Clarithromycin—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00428	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000119	0.00427	CbGpPWpGaD
Clarithromycin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000658	CcSEcCtD
Clarithromycin—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000118	0.00423	CbGpPWpGaD
Clarithromycin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000651	CcSEcCtD
Clarithromycin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000646	CcSEcCtD
Clarithromycin—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000113	0.00407	CbGpPWpGaD
Clarithromycin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000632	CcSEcCtD
Clarithromycin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000629	CcSEcCtD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000112	0.00403	CbGpPWpGaD
Clarithromycin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000616	CcSEcCtD
Clarithromycin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000612	CcSEcCtD
Clarithromycin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00061	CcSEcCtD
Clarithromycin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000606	CcSEcCtD
Clarithromycin—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00388	CbGpPWpGaD
Clarithromycin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000582	CcSEcCtD
Clarithromycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.00374	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000102	0.00367	CbGpPWpGaD
Clarithromycin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000563	CcSEcCtD
Clarithromycin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000561	CcSEcCtD
Clarithromycin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00056	CcSEcCtD
Clarithromycin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000557	CcSEcCtD
Clarithromycin—Angioedema—Prednisone—chronic obstructive pulmonary disease	9.94e-05	0.000554	CcSEcCtD
Clarithromycin—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.9e-05	0.00355	CbGpPWpGaD
Clarithromycin—Malaise—Prednisone—chronic obstructive pulmonary disease	9.81e-05	0.000547	CcSEcCtD
Clarithromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.79e-05	0.00351	CbGpPWpGaD
Clarithromycin—Vertigo—Prednisone—chronic obstructive pulmonary disease	9.78e-05	0.000545	CcSEcCtD
Clarithromycin—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.76e-05	0.0035	CbGpPWpGaD
Clarithromycin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	9.71e-05	0.000541	CcSEcCtD
Clarithromycin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	9.56e-05	0.000533	CcSEcCtD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	9.56e-05	0.00343	CbGpPWpGaD
Clarithromycin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.55e-05	0.00343	CbGpPWpGaD
Clarithromycin—Convulsion—Prednisone—chronic obstructive pulmonary disease	9.43e-05	0.000525	CcSEcCtD
Clarithromycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.33e-05	0.00335	CbGpPWpGaD
Clarithromycin—Myalgia—Prednisone—chronic obstructive pulmonary disease	9.26e-05	0.000516	CcSEcCtD
Clarithromycin—Anxiety—Prednisone—chronic obstructive pulmonary disease	9.23e-05	0.000514	CcSEcCtD
Clarithromycin—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.21e-05	0.00331	CbGpPWpGaD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	9.2e-05	0.000513	CcSEcCtD
Clarithromycin—Discomfort—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.00051	CcSEcCtD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	9.01e-05	0.00323	CbGpPWpGaD
Clarithromycin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	9e-05	0.000502	CcSEcCtD
Clarithromycin—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.99e-05	0.00323	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	8.99e-05	0.00323	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	8.99e-05	0.00323	CbGpPWpGaD
Clarithromycin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	8.88e-05	0.000495	CcSEcCtD
Clarithromycin—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	8.86e-05	0.00318	CbGpPWpGaD
Clarithromycin—Infection—Prednisone—chronic obstructive pulmonary disease	8.82e-05	0.000492	CcSEcCtD
Clarithromycin—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	8.76e-05	0.00315	CbGpPWpGaD
Clarithromycin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	8.71e-05	0.000485	CcSEcCtD
Clarithromycin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.000481	CcSEcCtD
Clarithromycin—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.61e-05	0.00309	CbGpPWpGaD
Clarithromycin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	8.58e-05	0.000478	CcSEcCtD
Clarithromycin—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.51e-05	0.00305	CbGpPWpGaD
Clarithromycin—Anorexia—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000472	CcSEcCtD
Clarithromycin—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.41e-05	0.00302	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	8.27e-05	0.00297	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.26e-05	0.00296	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.14e-05	0.00292	CbGpPWpGaD
Clarithromycin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.09e-05	0.000451	CcSEcCtD
Clarithromycin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.08e-05	0.00045	CcSEcCtD
Clarithromycin—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000448	CcSEcCtD
Clarithromycin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	7.97e-05	0.000444	CcSEcCtD
Clarithromycin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.9e-05	0.00284	CbGpPWpGaD
Clarithromycin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000436	CcSEcCtD
Clarithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.72e-05	0.00277	CbGpPWpGaD
Clarithromycin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.00043	CcSEcCtD
Clarithromycin—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	7.71e-05	0.00277	CbGpPWpGaD
Clarithromycin—Rash—Prednisolone—chronic obstructive pulmonary disease	7.71e-05	0.000429	CcSEcCtD
Clarithromycin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.7e-05	0.000429	CcSEcCtD
Clarithromycin—Fatigue—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.000427	CcSEcCtD
Clarithromycin—Headache—Prednisolone—chronic obstructive pulmonary disease	7.66e-05	0.000427	CcSEcCtD
Clarithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.62e-05	0.00274	CbGpPWpGaD
Clarithromycin—Constipation—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.000423	CcSEcCtD
Clarithromycin—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.59e-05	0.00272	CbGpPWpGaD
Clarithromycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.57e-05	0.00272	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.48e-05	0.00269	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.37e-05	0.00264	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	7.33e-05	0.00263	CbGpPWpGaD
Clarithromycin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.32e-05	0.000408	CcSEcCtD
Clarithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.27e-05	0.00261	CbGpPWpGaD
Clarithromycin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.000405	CcSEcCtD
Clarithromycin—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.26e-05	0.000405	CcSEcCtD
Clarithromycin—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.19e-05	0.00258	CbGpPWpGaD
Clarithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.18e-05	0.00258	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.15e-05	0.00257	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.09e-05	0.00255	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.06e-05	0.00253	CbGpPWpGaD
Clarithromycin—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000393	CcSEcCtD
Clarithromycin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.02e-05	0.000391	CcSEcCtD
Clarithromycin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.02e-05	0.000391	CcSEcCtD
Clarithromycin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.94e-05	0.00249	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	6.83e-05	0.00245	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.66e-05	0.00239	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.58e-05	0.00236	CbGpPWpGaD
Clarithromycin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	6.54e-05	0.000365	CcSEcCtD
Clarithromycin—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000355	CcSEcCtD
Clarithromycin—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.28e-05	0.00035	CcSEcCtD
Clarithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.26e-05	0.00225	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.14e-05	0.00221	CbGpPWpGaD
Clarithromycin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000339	CcSEcCtD
Clarithromycin—SLC22A7—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6e-05	0.00215	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.97e-05	0.00214	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.9e-05	0.00212	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.89e-05	0.00211	CbGpPWpGaD
Clarithromycin—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.87e-05	0.000327	CcSEcCtD
Clarithromycin—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	5.79e-05	0.00208	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	5.75e-05	0.00206	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.65e-05	0.00203	CbGpPWpGaD
Clarithromycin—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.65e-05	0.000315	CcSEcCtD
Clarithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.61e-05	0.00201	CbGpPWpGaD
Clarithromycin—Rash—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000312	CcSEcCtD
Clarithromycin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000312	CcSEcCtD
Clarithromycin—Headache—Prednisone—chronic obstructive pulmonary disease	5.56e-05	0.00031	CcSEcCtD
Clarithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.54e-05	0.00199	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.53e-05	0.00199	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.48e-05	0.00197	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.46e-05	0.00196	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.41e-05	0.00194	CbGpPWpGaD
Clarithromycin—Nausea—Prednisone—chronic obstructive pulmonary disease	5.27e-05	0.000294	CcSEcCtD
Clarithromycin—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.2e-05	0.00187	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.19e-05	0.00186	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.13e-05	0.00184	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.13e-05	0.00184	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.08e-05	0.00182	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.98e-05	0.00179	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.68e-05	0.00168	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.61e-05	0.00166	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.55e-05	0.00163	CbGpPWpGaD
Clarithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.55e-05	0.00163	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.24e-05	0.00152	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	4.22e-05	0.00151	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.21e-05	0.00151	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	4.18e-05	0.0015	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.18e-05	0.0015	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.04e-05	0.00145	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.02e-05	0.00144	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4e-05	0.00144	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.96e-05	0.00142	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.96e-05	0.00142	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.95e-05	0.00142	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.87e-05	0.00139	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.83e-05	0.00138	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.79e-05	0.00136	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.79e-05	0.00136	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	3.73e-05	0.00134	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.65e-05	0.00131	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.61e-05	0.0013	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.61e-05	0.0013	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.59e-05	0.00129	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.55e-05	0.00127	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.47e-05	0.00124	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.42e-05	0.00123	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.33e-05	0.00119	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.3e-05	0.00119	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.28e-05	0.00118	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.26e-05	0.00117	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.23e-05	0.00116	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.16e-05	0.00113	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.14e-05	0.00113	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.13e-05	0.00112	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.09e-05	0.00111	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.05e-05	0.00109	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.93e-05	0.00105	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.77e-05	0.000996	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.77e-05	0.000994	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.74e-05	0.000982	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.69e-05	0.000967	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.55e-05	0.000915	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.52e-05	0.000904	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.51e-05	0.000903	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.51e-05	0.000899	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.42e-05	0.000867	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.000856	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.31e-05	0.000827	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.14e-05	0.000769	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.12e-05	0.000762	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.09e-05	0.00075	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.08e-05	0.000748	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.04e-05	0.000731	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.03e-05	0.00073	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.01e-05	0.000723	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.94e-05	0.000698	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.94e-05	0.000695	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.89e-05	0.000679	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.84e-05	0.000659	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.8e-05	0.000645	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	0.000608	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.69e-05	0.000607	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.67e-05	0.000599	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.62e-05	0.000583	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.62e-05	0.000582	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.55e-05	0.000557	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.54e-05	0.000554	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.52e-05	0.000546	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.51e-05	0.000542	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.47e-05	0.000528	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.46e-05	0.000522	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.45e-05	0.00052	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.41e-05	0.000507	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.39e-05	0.0005	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.33e-05	0.000477	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.3e-05	0.000466	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.29e-05	0.000462	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.28e-05	0.000458	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.25e-05	0.00045	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.000441	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.22e-05	0.000439	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000432	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.16e-05	0.000418	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.14e-05	0.000409	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.13e-05	0.000404	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.11e-05	0.000399	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.1e-05	0.000394	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.05e-05	0.000377	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.03e-05	0.000369	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.02e-05	0.000366	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.01e-05	0.000361	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1e-05	0.00036	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.74e-06	0.000349	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.46e-06	0.00034	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.38e-06	0.000337	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.23e-06	0.000331	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.89e-06	0.000319	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.87e-06	0.000318	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.77e-06	0.000315	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	8.36e-06	0.0003	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.17e-06	0.000293	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8e-06	0.000287	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	8e-06	0.000287	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.89e-06	0.000283	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.78e-06	0.000279	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.7e-06	0.000276	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.59e-06	0.000273	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.25e-06	0.00026	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.08e-06	0.000254	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.87e-06	0.000247	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.84e-06	0.000246	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.77e-06	0.000243	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.71e-06	0.000241	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.17e-06	0.000222	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.15e-06	0.000221	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.06e-06	0.000218	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	6.04e-06	0.000217	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.78e-06	0.000207	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.69e-06	0.000204	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.65e-06	0.000203	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.36e-06	0.000192	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.74e-06	0.00017	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.68e-06	0.000168	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.67e-06	0.000168	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.56e-06	0.000164	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.47e-06	0.00016	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.36e-06	0.000157	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.36e-06	0.000156	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.13e-06	0.000148	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.64e-06	0.000131	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.48e-06	0.000125	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.81e-06	0.000101	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.69e-06	9.65e-05	CbGpPWpGaD
